Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

Affiliations

• ¹ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
• ² Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, Meran/Merano, Italy.
• ³ Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
• ⁴ Department of Artificial Intelligence and Human Interfaces and Intelligent Data Analytics Lab Salzburg, University of Salzburg, Salzburg, Austria.
• ⁵ Faculty of Management and Economics, University of Klagenfurt, Klagenfurt, Austria.
• ⁶ Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
• ⁷ Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
• ⁸ Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: matthias.preusser@meduniwien.ac.at.